再生医療における人工知能市場：技術、提供、用途、エンドユーザー別-2024-2030年の世界予測

再生医療における人工知能市場規模は2023年に5,963万米ドルと推定され、2024年には7,238万米ドルに達し、CAGR 22.05％で2030年には2億4,063万米ドルに達すると予測されます。

人工知能（AI）は、人体内で損傷したり失われたりした組織や臓器を修復、置換、再生するための学際的アプローチであるため、再生医療においてますます重要性を増しています。AI技術は、研究を加速し、患者の治療を強化し、治療結果を改善するために、再生医療の様々な側面に適用されています。再生医療市場におけるAIは、機械学習アルゴリズム、深層学習システム、自然言語処理ツール、ロボット工学などのAI技術を幹細胞療法、組織工学、免疫療法、遺伝子編集技術に統合することを包含しています。官民両部門における研究開発活動への資金提供の増加は、AIなどの先端技術の採用を加速させています。加えて、がんや心血管疾患などの慢性疾患の有病率が上昇していることから、AIを活用した再生医療が提供する画期的なソリューションによってのみ対応可能な革新的な治療アプローチに対する需要が高まっており、市場の成長がさらに高まっています。しかし、AIアルゴリズムのトレーニングに使用される患者情報の機密性のためにデータプライバシーに関する懸念が生じ、AIシステムによって使用される複雑なアルゴリズムが市場導入の妨げとなっています。個別化治療の登場と次世代シークエンシング（NGS）技術の進歩により、高度な分析手法を必要とする膨大な量のデータが生成されており、これが再生医療におけるAIの応用に新たな機会をもたらしています。

地域別インサイト

南北アメリカは、大規模な投資やパートナーシップ、市場におけるイノベーションに継続的に注力している主要市場プレイヤーの存在により、再生医療における人工知能市場において重要な地位を占めています。さらに、政府主導により、臓器再生と修復のための新しい治療アプローチを開発するためにAI技術を統合することに重点を置く様々な分野の研究者が集まっています。欧州連合（EU）では、Horizon 2020などの資金提供プログラムが、AIベースの再生医療プロジェクトを推進するために多額のリソースを割り当てています。政府は、機械学習アルゴリズムを使用して人間のあらゆる細胞タイプをマッピングするプロジェクトをいくつか立ち上げており、この地域の市場導入にさらに拍車をかけています。APAC地域は、政府の多額の投資を背景に、AIベースの再生医療を急速に進めています。大手企業は、再生療法を含む医療問題にAI技術を適用する専門のヘルスケア部門を設立しています。政府はまた、ヘルスケアやバイオテクノロジーなどの産業を支援するため、再生医療向けのAI技術を開発する戦略的イニシアチブを打ち出しており、同地域の市場導入をさらに促進しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、再生医療における人工知能市場におけるベンダーの市場ポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、再生医療における人工知能市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、再生医療における人工知能市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および希少疾患の罹患率の増加
    • 精密医薬品と幹細胞療法に対する消費者の嗜好の高まり
    • ヘルスケア分野におけるAI導入を支援する政府の取り組み
  • 抑制要因
    • 再生医療におけるAIベースのソリューションに関連する高コスト
  • 機会
    • 医薬品の発見と開発を改善する技術の進歩
    • AI導入のための資金と投資の増加
  • 課題
    • データのプライバシーに関する懸念と熟練した専門家の不足
• 市場セグメンテーション分析
  • テクノロジー：主要な生物学的構造を正確かつ効率的に検出するためのコンピュータービジョンテクノロジーの大幅な導入
  • 提供内容：再生医療におけるAIアプリケーションに必要な計算能力を提供するハードウェア
  • 応用：AL技術の創薬応用における潜在的な活用
  • エンドユーザー：製薬企業とバイオテクノロジー企業は、AIを活用して創薬を加速することに注力しています。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 再生医療における人工知能市場：技術別

• コンピュータビジョン
• コンテキスト認識コンピューティング
• 機械学習
• 自然言語処理

第7章 再生医療における人工知能市場：提供別

• ハードウェア
• サービス
• ソフトウェア

第8章 再生医療における人工知能市場：用途別

• サイバーセキュリティ
• 創薬
• 不正行為検出
• ヘルスケア支援ロボット
• 医療画像診断
• 患者データとリスク分析
• 精密医療

第9章 再生医療における人工知能市場：エンドユーザー別

• ヘルスケア支払者
• 病院と医療機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカの再生医療における人工知能市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の再生医療における人工知能市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの再生医療における人工知能市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アクソロトル・バイオロジックスとカーメル・セラピューティクスが合併契約を締結
  • EprediaとAiforiaがRegenMed Hubイノベーションアクセラレーターに参加、再生医療におけるPHCグループのプレゼンス拡大パートナーシップが新たなRegenMed臨床試験カタリストプログラムへの道を開く
  • ウィプロとパンドラムが提携し、人工知能で再生医療を加速
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET DYNAMICS
• FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEMORY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEMORY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NETWORK, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NETWORK, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PROCESSOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CYBERSECURITY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CYBERSECURITY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FRAUD DETECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FRAUD DETECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEDICAL IMAGING & DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEDICAL IMAGING & DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PATIENT DATA & RISK ANALYSIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PATIENT DATA & RISK ANALYSIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 89. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 90. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 91. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 92. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 93. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 94. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 95. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 96. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 97. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 98. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 133. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 134. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 135. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 136. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 137. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 138. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 139. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 144. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 145. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 146. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 147. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 148. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 149. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 154. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 155. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 156. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 157. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 158. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 159. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 164. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 165. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 166. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 167. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 168. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 169. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 172. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 173. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 174. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 175. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 176. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 177. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 178. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 179. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 182. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 183. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 184. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 185. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 186. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 187. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 188. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 189. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 194. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 195. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 196. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 197. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 198. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 199. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 204. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 205. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 206. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 207. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 208. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 209. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 212. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 213. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 214. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 216. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 218. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 222. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 223. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 224. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 225. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 226. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 227. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 228. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 229. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 232. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 233. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 234. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 235. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 236. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 237. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 238. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 239. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 244. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 245. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 246. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 247. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 248. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 249. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 265. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 266. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 267. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
• TABLE 268. DENMARK ARTIFICIAL INTELLIGENC

[185 Pages Report] The Artificial Intelligence in Regenerative Medicine Market size was estimated at USD 59.63 million in 2023 and expected to reach USD 72.38 million in 2024, at a CAGR 22.05% to reach USD 240.63 million by 2030.

Artificial intelligence (AI) is increasingly important in regenerative medicine as it is a multidisciplinary approach to repairing, replacing, or regenerating damaged or lost tissues and organs within the human body. AI technologies are applied to various aspects of regenerative medicine to accelerate research, enhance patient care, and improve treatment outcomes. The AI in the regenerative medicine market encompasses integrating AI technologies such as machine learning algorithms, deep learning systems, natural language processing tools, and robotics with stem cell therapy, tissue engineering, immunotherapies, and gene editing techniques. Increased funding for research & development activities in both public and private sectors has accelerated the adoption of advanced technologies such as AI. Additionally, the rising prevalence of chronic conditions such as cancer and cardiovascular diseases has increased demand for innovative treatment approaches that can only be met through groundbreaking solutions provided by AI-enabled regenerative medicine, further increasing market growth. However, data privacy concerns arise due to the sensitive nature of patient information used for training AI algorithms, and the complex algorithms used by AI systems hamper market adoption. The advent of personalized therapy and advances in next-generation sequencing (NGS) technologies have generated vast amounts of data requiring sophisticated analysis methods; this poses yet another opportunity for AI's application within the regenerative medicine landscape.

Regional Insights

The Americas hold a significant landscape in the artificial intelligence in regenerative medicine market owing to significant investments and partnerships and the presence of key market players continuously focusing on innovations in the market. Additionally, the government initiative brings together researchers from various fields who focus on integrating AI technologies to develop novel therapeutic approaches for organ regeneration and repair. In the European Union, funding programs such as Horizon 2020 have allocated substantial resources to advance AI-based regenerative medicine projects. The government has launched several projects to map every human cell type using machine learning algorithms, further fueling the region's market adoption. APAC region is rapidly advancing in AI-based regenerative medicine, backed by significant government investments. Leading companies have established dedicated healthcare units that apply AI technologies to medical issues, including regenerative therapies. The government has also launched strategic initiatives to develop AI technologies for regenerative medicine to support industries such as healthcare and biotechnology, further fueling market adoption in the region.

Market Insights

• Market Dynamics

The market dynamics represent an ever-changing landscape of the Artificial Intelligence in Regenerative Medicine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Increasing prevalence of chronic and rare diseases
  • Growing consumer preference for precision medicines and stem cell therapies
  • Supportive government initiatives for deployment of AI in healthcare sector

• Market Restraints
  • High costs associated with AI-based solutions for regenerative medicine

• Market Opportunities
  • Advancements in technologies for improved drug discovery and development
  • Rising funding and investments for deployment of AI

• Market Challenges
  • Concerns regarding data privacy coupled with limited availability of skilled professionals
• Market Segmentation Analysis
  • Technology: Significant adoption of computer vision technology for accurate and efficient detection of key biological structures
  • Offering: Hardware provides the necessary computational power in AI applications in regenerative medicine
  • Application: Potential utilization of AL technology in drug discovery applications
  • End-User: Pharmaceutical and biotechnology companies focus on leveraging AI to accelerate drug discovery

• Market Disruption Analysis
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Intelligence in Regenerative Medicine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Intelligence in Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Axolotl Biologix and Carmell Therapeutics Enter Merger Deal

Axolotl and Carmell entered into a merger agreement to advance Artificial Intelligence (AI) in Regenerative Medicine. This merger will create a company with the largest AI platform for optimizing human tissue development. Both companies will share their AI, data science, and 3D organ fabrication expertise. Through this collaboration, they aim to facilitate innovation in cellular therapies and drug development, strongly focusing on improving patient outcomes. [Published On: 2023-09-13]

Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program

PHC Group announced to expand its presence in regenerative medicine by joining the RegeneratOR Innovation Accelerator. The combination of diagnostic microscopic imaging and AI has created a bridge between drug discovery, translational, and clinical research programs, enabling a better understanding of disease states. [Published On: 2023-01-19]

Wipro and Pandorum Partner to Accelerate Regenerative Medicine with Artificial Intelligence

Wipro entered into a strategic partnership with Pandorum Technologies, aiming to expedite advancements in regenerative medicine through AI. This collaboration between the two companies involves the development of therapies and diagnostics, leveraging predictive analytics and multi-modal data integration. By combining Pandorum's expertise in tissue engineering technology with Wipro's extensive experience in building AI-driven medical solutions, the partnership seeks to accelerate the progress of innovative regenerative therapies. [Published On: 2022-03-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Intelligence in Regenerative Medicine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Cognetivity Ltd., F. Hoffmann-La Roche Ltd., Intel Corporation, Medtronic PLC, Merck KGaA, Microsoft Corporation, NANO-X IMAGING LTD., Novo Nordisk A/S, NVIDIA Corporation, Sanofi SA, Tempus Labs, Inc., and Wipro Limited.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Technology
  • Computer Vision
  • Context-Aware Computing
  • Machine Learning
  • Natural Language Processing

• Offering
  • Hardware
    • Memory
    • Network
    • Processor

• Services
• Software

• Application
  • Cybersecurity
  • Drug Discovery
  • Fraud Detection
  • Healthcare Assistance Robots
  • Medical Imaging & Diagnostics
  • Patient Data & Risk Analysis
  • Precision Medicine

• End-User
  • Healthcare Payers
  • Hospitals & Providers
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic and rare diseases
    • 5.1.1.2. Growing consumer preference for precision medicines and stem cell therapies
    • 5.1.1.3. Supportive government initiatives for deployment of AI in healthcare sector
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with AI-based solutions for regenerative medicine
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in technologies for improved drug discovery and development
    • 5.1.3.2. Rising funding and investments for deployment of AI
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding data privacy coupled with limited availability of skilled professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Significant adoption of computer vision technology for accurate and efficient detection of key biological structures
  • 5.2.2. Offering: Hardware provides the necessary computational power in AI applications in regenerative medicine
  • 5.2.3. Application: Potential utilization of AL technology in drug discovery applications
  • 5.2.4. End-User: Pharmaceutical and biotechnology companies focus on leveraging AI to accelerate drug discovery
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Artificial Intelligence in Regenerative Medicine Market, by Technology

• 6.1. Introduction
• 6.2. Computer Vision
• 6.3. Context-Aware Computing
• 6.4. Machine Learning
• 6.5. Natural Language Processing

7. Artificial Intelligence in Regenerative Medicine Market, by Offering

• 7.1. Introduction
• 7.2. Hardware
• 7.3. Services
• 7.4. Software

8. Artificial Intelligence in Regenerative Medicine Market, by Application

• 8.1. Introduction
• 8.2. Cybersecurity
• 8.3. Drug Discovery
• 8.4. Fraud Detection
• 8.5. Healthcare Assistance Robots
• 8.6. Medical Imaging & Diagnostics
• 8.7. Patient Data & Risk Analysis
• 8.8. Precision Medicine

9. Artificial Intelligence in Regenerative Medicine Market, by End-User

• 9.1. Introduction
• 9.2. Healthcare Payers
• 9.3. Hospitals & Providers
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Artificial Intelligence in Regenerative Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Axolotl Biologix and Carmell Therapeutics Enter Merger Deal
  • 13.3.2. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
  • 13.3.3. Wipro and Pandorum Partner to Accelerate Regenerative Medicine with Artificial Intelligence
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio